The goal of the clinical trial is to test whether a mental health program that is delivered through the Internet works well for children and adolescents with cystic fibrosis (CF) and their healthy siblings. The main questions it aims to answer are: * Does the program improve the mental health such as depression and anxiety symptoms? * Does the program improve overall quality of life? * Does the program improve self-efficacy - an individual's belief in their ability to complete tasks to achieve their goals? Participants will: * Fill out an online survey asking questions about their personal and health information, as well as their mental health before the program * Complete the online mental health program * Fill out an online survey asking questions about their mental health after completing the program, and 1-month and 3-months following completing the program Participants be compared against another group of children with CF and their healthy siblings who are on a waitlist and receiving usual CF treatment. Researchers will compare participants scores before starting the program with their scores immediately following completing the program, 1-month, and 3-month after completing the program. Researchers hope to develop a program that improves mental health, quality of life, self-efficacy, and knowledge about CF.
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Change from Baseline in the State-Trait Anxiety Inventory for Children (STAI-C) at Week 3-6
Timeframe: Baseline and Week 3-6 (post-intervention)
Change from Baseline in the State-Trait Anxiety Inventory for Children (STAI-C) at 1 Month
Timeframe: Baseline and 1-month follow up
Change from Baseline in the State-Trait Anxiety Inventory for Children (STAI-C) at 3 Months
Timeframe: Baseline and 3-months follow up
Change from Baseline in the Children's Depression Inventory-2 (CDI-2) at Week 3-6
Timeframe: Baseline and Week 3-6 (post-intervention)
Change from Baseline in the Children's Depression Inventory-2 (CDI-2) at 1 month
Timeframe: Baseline and 1-month follow up
Change from Baseline in the Children's Depression Inventory-2 (CDI-2) at 3 months
Timeframe: Baseline and 3-months follow up
Change from Baseline in the Childhood Illness Attitudes Scale (CIAS) at Week 3-6
Timeframe: Baseline and Week 3-6 (post-intervention)
Change from Baseline in the Childhood Illness Attitudes Scale (CIAS) at 1 month
Timeframe: Baseline and 1-month follow up
Change from Baseline in the Childhood Illness Attitudes Scale (CIAS) at 3 months
Timeframe: Baseline and 3-months follow up
Change from Baseline in the Pediatric Quality of Life Inventory (PedsQL-4.0) at Week 3-6
Timeframe: Baseline and Week 3-6 (post-intervention)
Change from Baseline in the Pediatric Quality of Life Inventory (PedsQL-4.0) at 1 month
Timeframe: Baseline and 1-month follow up
Change from Baseline in the Pediatric Quality of Life Inventory (PedsQL-4.0) at 3 months
Timeframe: Baseline and 3-months follow up
Change from Baseline in the Self-Efficacy Questionnaire for Children (SEQ-2) at Week 3-6
Timeframe: Baseline and Week 3-6 (post-intervention)
Change from Baseline in the Self-Efficacy Questionnaire for Children (SEQ-2) at 1 Month
Timeframe: Baseline and 1-month follow up
Change from Baseline in the Self-Efficacy Questionnaire for Children (SEQ-2) at 3 Months
Timeframe: Baseline and 3-months follow up
Change from Baseline in the Disease Knowledge Questionnaire at Week 3-6
Timeframe: Baseline and Week 3-6 (post-intervention)
Change from Baseline in the Disease Knowledge Questionnaire at 1 Month
Timeframe: Baseline and 1-month follow up
Change from Baseline in the Disease Knowledge Questionnaire at 3 Months
Timeframe: Baseline and 3-months follow up
Participants Qualitative Perception of Program Satisfaction at Week 3-6
Timeframe: Week 3-6 (post-intervention)